Diagnosis of sleep apnea
- PMID: 15289750
Diagnosis of sleep apnea
Abstract
Obstructive sleep apnea syndrome (OSAS) is characterized by repeated oropharyngeal occlusions occurring during sleep. The prevalence of moderate OSAS (with an apnea-hypopnea index = or >15/h) is 9% and 4% in male and female, respectively. It is associated with an abnormally high frequency of cardiovascular disease (hypertension, stroke, coronary heart disease) and excessive daytime sleepiness responsible for an increased frequency of work and road accidents. Because the treatment of OSAS provides many benefits to patients and society, it is very important to obtain an early diagnosis. The diagnosis of OSAS is based on the combination of characteristic clinical features plus compatible findings on instrumental tests in which multiple physiologic signals are monitored simultaneously during a night of sleep. A full night polysomnography, conducted by a technologist in a sleep laboratory, is the gold standard for the diagnosis of suspected OSAS, but the capacity for performing polysomnography is limited. On the basis of the high incidence and prevalence of OSAS, of the limited number of sleep laboratories, long waiting times and high costs recommendations have been formulated for the use of unattended portable systems in the assessment of OSAS. The main clinical aspects of of OSAS, the diagnostic approach with full night polysomnography and unattended portable systems, the differential diagnosis and some examples of cardiorespiratory portable monitoring are presented in this paper.
Similar articles
-
Risk for Obstructive Sleep Apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study.Am J Hypertens. 2008 Jul;21(7):832-5. doi: 10.1038/ajh.2008.184. Epub 2008 May 1. Am J Hypertens. 2008. PMID: 18451807
-
Daytime sleepiness and polysomnography in obstructive sleep apnea patients.Sleep Med. 2008 Oct;9(7):727-31. doi: 10.1016/j.sleep.2008.02.006. Epub 2008 May 15. Sleep Med. 2008. PMID: 18482866
-
Risk factors for obstructive sleep apnea syndrome screening in mood disorder patients.Psychiatry Clin Neurosci. 2009 Jun;63(3):385-91. doi: 10.1111/j.1440-1819.2009.01956.x. Psychiatry Clin Neurosci. 2009. PMID: 19566771
-
[Sleep apnea syndromes and cardiovascular disease].Bull Acad Natl Med. 2005 Mar;189(3):445-59; discussion 460-4. Bull Acad Natl Med. 2005. PMID: 16149210 Review. French.
-
Sleep apnea: clinical investigations in humans.Sleep Med. 2007 Jun;8(4):400-26. doi: 10.1016/j.sleep.2007.03.003. Epub 2007 May 2. Sleep Med. 2007. PMID: 17478121 Review.
Cited by
-
Comparison of Predictor of Desaturation Disorders and Daytime Sleepiness Based On Epworth Sleepiness Scale and STOP-BANG Questionnaires in Mild to Moderate Obstructive Sleep Apnea Patients.Open Access Maced J Med Sci. 2018 Aug 18;6(9):1617-1621. doi: 10.3889/oamjms.2018.258. eCollection 2018 Sep 25. Open Access Maced J Med Sci. 2018. PMID: 30337975 Free PMC article.
-
Not-So-Sweet Dreams: Plasma and IgG N-Glycome in the Severe Form of the Obstructive Sleep Apnea.Biomolecules. 2023 May 23;13(6):880. doi: 10.3390/biom13060880. Biomolecules. 2023. PMID: 37371460 Free PMC article.
-
Investigation of obstructive sleep apnoea syndrome prevalence among long-distance drivers from Zonguldak, Turkey.Multidiscip Respir Med. 2013 Feb 6;8(1):10. doi: 10.1186/2049-6958-8-10. Multidiscip Respir Med. 2013. PMID: 23388467 Free PMC article.
-
Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.J Endocrinol Invest. 2010 Mar;33(3):192-6. doi: 10.1007/BF03346580. J Endocrinol Invest. 2010. PMID: 20418654 Review.
-
Screening the risk of obstructive sleep apnea by utilizing supervised learning techniques based on anthropometric features and snoring events.Digit Health. 2023 Mar 6;9:20552076231152751. doi: 10.1177/20552076231152751. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 36896329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources